https://scholars.lib.ntu.edu.tw/handle/123456789/431383
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.author | Huang, Wei-Chun | en_US |
dc.contributor.author | Hsu, Chih-Hsin | en_US |
dc.contributor.author | Sung, Shih-Hsien | en_US |
dc.contributor.author | WEN-JENG HSUEH | en_US |
dc.contributor.author | Chu, Chun-Yuan | en_US |
dc.contributor.author | Chang, Chih-Ping | en_US |
dc.contributor.author | Chiu, Yu-Wei | en_US |
dc.contributor.author | Wu, Chun-Hsien | en_US |
dc.contributor.author | Chang, Wei-Ting | en_US |
dc.contributor.author | Lin, Lin | en_US |
dc.contributor.author | Lin, Shoa-Lin | en_US |
dc.contributor.author | Cheng, Chin-Chang | en_US |
dc.contributor.author | YI-JU WU | en_US |
dc.contributor.author | Wu, Shu-Hao | en_US |
dc.contributor.author | Hsieh, Tsu-Yi | en_US |
dc.contributor.author | HSAO-HSUN HSU | en_US |
dc.contributor.author | Fu, Morgan | en_US |
dc.contributor.author | Dai, Zen-Kong | en_US |
dc.contributor.author | PING-HUNG KUO | en_US |
dc.contributor.author | HWANG, JUEY-JEN | en_US |
dc.contributor.author | Cheng, Shu-Meng | en_US |
dc.contributor.author | TSOC pulmonary hypertension committee | en_US |
dc.creator | Huang, Wei-Chun;Hsu, Chih-Hsin;Sung, Shih-Hsien;Wen-Jeng Hsueh;Chu, Chun-Yuan;Chang, Chih-Ping;Chiu, Yu-Wei;Wu, Chun-Hsien;Chang, Wei-Ting;Lin, Lin;Lin, Shoa-Lin;Cheng, Chin-Chang;Yi-Ju Wu;Wu, Shu-Hao;Hsieh, Tsu-Yi;Hsao-Hsun Hsu;Fu, Morgan;Dai, Zen-Kong;Kuo, Ping-Hung;Hwang, Juey-Jen;Cheng, Shu-Meng | - |
dc.date.accessioned | 2019-11-18T01:23:44Z | - |
dc.date.available | 2019-11-18T01:23:44Z | - |
dc.date.issued | 2019-03-26 | - |
dc.identifier.issn | 0929-6646 | - |
dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/431383 | - |
dc.description.abstract | Pulmonary arterial hypertension (PAH) is characterized as a progressive and sustained increase in pulmonary vascular resistance, which may induce right ventricular failure. In 2014, the Working Group on Pulmonary Hypertension of the Taiwan Society of Cardiology (TSOC) conducted a review of data and developed a guideline for the management of PAH.4 In recent years, several advancements in diagnosis and treatment of PAH has occurred. Therefore, the Working Group on Pulmonary Hypertension of TSOC decided to come up with a focused update that addresses clinically important advances in PAH diagnosis and treatment. This 2018 focused update deals with: (1) the role of echocardiography in PAH; (2) new diagnostic algorithm for the evaluation of PAH; (3) comprehensive prognostic evaluation and risk assessment; (4) treatment goals and follow-up strategy; (5) updated PAH targeted therapy; (6) combination therapy and goal-orientated therapy; (7) updated treatment for PAH associated with congenital heart disease; (8) updated treatment for PAH associated with connective tissue disease; and (9) updated treatment for chronic thromboembolic pulmonary hypertension. | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | Journal of the Formosan Medical Association = Taiwan yi zhi | en_US |
dc.subject | Guideline; Pulmonary arterial hypertension; Pulmonary hypertension | en_US |
dc.subject.classification | [SDGs]SDG3 | - |
dc.subject.other | ambrisentan; anticoagulant agent; beraprost; bosentan; calcium channel blocking agent; diuretic agent; endothelin receptor antagonist; guanylate cyclase activator; iloprost; macitentan; phosphodiesterase V inhibitor; prostacyclin; prostacyclin derivative; prostanoid; riociguat; selexipag; sildenafil; tadalafil; treprostinil; algorithm; Article; blood vessel reactivity; chronic thromboembolic pulmonary hypertension; clinical evaluation; combination drug therapy; congenital heart disease; connective tissue disease; Eisenmenger complex; follow up; heart right ventricle failure; human; lung vascular resistance; oxygen therapy; percutaneous transluminal angioplasty; practice guideline; prognostic assessment; pulmonary hypertension; pulmonary veno-occlusive disease; randomized controlled trial (topic); risk assessment; risk factor; screening; systemic lupus erythematosus; systemic sclerosis; Taiwan; transthoracic echocardiography; tricuspid valve regurgitation; venous thromboembolism; cardiology; medical society; pulmonary hypertension; Cardiology; Humans; Practice Guidelines as Topic; Pulmonary Arterial Hypertension; Societies, Medical; Taiwan | - |
dc.title | 2018 TSOC guideline focused update on diagnosis and treatment of pulmonary arterial hypertension | en_US |
dc.type | journal article | en |
dc.identifier.doi | 10.1016/j.jfma.2018.12.009 | - |
dc.identifier.pmid | 30926248 | - |
dc.identifier.scopus | 2-s2.0-85063333446 | - |
dc.identifier.url | https://api.elsevier.com/content/abstract/scopus_id/85063333446 | - |
item.openairecristype | http://purl.org/coar/resource_type/c_6501 | - |
item.openairetype | journal article | - |
item.languageiso639-1 | en | - |
item.grantfulltext | none | - |
item.cerifentitytype | Publications | - |
item.fulltext | no fulltext | - |
crisitem.author.dept | Internal Medicine-NTUHHC | - |
crisitem.author.dept | Surgery-NTUH | - |
crisitem.author.dept | Surgery | - |
crisitem.author.dept | National Taiwan University Cancer Center (NTUCC) | - |
crisitem.author.dept | Internal Medicine-NTUH | - |
crisitem.author.dept | Internal Medicine | - |
crisitem.author.orcid | 0000-0001-6246-8803 | - |
crisitem.author.orcid | 0000-0002-0376-1206 | - |
crisitem.author.orcid | 0000-0003-3756-3395 | - |
crisitem.author.orcid | 0000-0001-6437-0455 | - |
crisitem.author.parentorg | NTU Hsin-Chu Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | National Taiwan University Hospital | - |
crisitem.author.parentorg | College of Medicine | - |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。